Quantitative Pulmonary Imaging Registry & Biorepository
University of Kansas Medical Center · NCT05530408
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 100
- US sites recruiting
- 1
- Study start
- May 24, 2022
- Record last updated
- May 6, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this project is to establish a registry and biorepository of images and biological samples from subjects undergoing novel pulmonary imaging methods to be used for future research aimed toward identifying clinical applications of imaging methods and toward understanding the physiological significance of imaging biomarkers. This registry and biorepository will accelerate the development of these imaging techniques and may lead toward future clinical adoption of quantitative pulmonary imaging.
Conditions: Pulmonary Disease
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- The participant is enrolling/has enrolled in a research study at the University of Kansas Medical Center that involves Pulmonary MRI and/or Pulmonary CT.
Exclusion Criteria
- The participant declines to participate.
Recruiting US locations
University of Kansas Medical Center
Kansas City, KS 66160
Site contact: Cristal Monge · 913-588-2473 · chernandez@kumc.edu
Study contacts (from the official record)
- Cristal Monge · 9135882473 · chernandez@kumc.edu
- Adam M Ruff, BS · 9135743932 · aruff@kumc.edu
Similar studies in Kansas
All healthy volunteers studies in Kansas →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination
Basilea Pharmaceutica
- Location
- Lenexa, KS
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1/Phase 2
A Study of BLB-201 RSV Vaccine in Infants and Children
Blue Lake Biotechnology Inc.
- Location
- Newton, KS + 13 other US sites
- Eligibility basics
- Ages 6 mo–5
- RecruitingHealthy volunteersPhase 1
Evaluation of VX-581 in Healthy Participants and in Participants With Cystic Fibrosis
Vertex Pharmaceuticals Incorporated
- Location
- Overland Park, KS
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1
A Study of RO7890597 in Healthy Adult Volunteers
Genentech, Inc.
- Location
- Lenexa, KS
- Eligibility basics
- Ages 18–65